Skip to main content
Top
Published in: Rheumatology International 5/2020

01-05-2020 | Intrauterine Growth Restriction | Case Based Review

Pregnancy and Takayasu arteritis: case-based review

Authors: Nirvana Bharuthram, Mohammed Tikly

Published in: Rheumatology International | Issue 5/2020

Login to get access

Abstract

Takayasu arteritis (TA) is a rare large vessel vasculitis that particularly affects women of child-bearing age. Management of pregnant patients with TA is often challenging due to the cardiovascular and cerebrovascular complications of the disease. We report two new cases of pregnancy in patients with TA and review all published cases from sub-Saharan Africa. Analysis of 16 pregnancies in 15 patients (including our two cases) showed that seven patients had radiographic Type V TA disease, namely involvement of the entire length of the aorta. Four patients were newly diagnosed with TA during pregnancy and two pregnancies were unbooked at time of first presentation. Seven pregnancies were complicated by disease flares (n = 4) and/or hypertension (n = 6). Four pregnancies resulted in preterm delivery and six required caesarean sections. There was one documented case of pre-eclampsia resulting in the only maternal death. Intrauterine growth restriction was documented in two of six pregnancies in which foetal ultrasonography was performed. There were four low birth weight infants and one fresh stillbirth (associated with the maternal death). In the handful of case reports of pregnancy in TA from sub-Saharan Africa, both maternal and foetal outcomes were generally good and similar to international findings. In a substantial proportion of patients, the diagnosis of TA was made in pregnancy, reflecting challenges of access to appropriate health care in resource constrained sub-Saharan Africa.
Literature
2.
go back to reference Langford CA, Fauci AS (2008) The vasculitis sundromes. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (eds) Harrisons Principles of Internal Medicine, 20e, McGraw-Hill, New york. Langford CA, Fauci AS (2008) The vasculitis sundromes. In: Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (eds) Harrisons Principles of Internal Medicine, 20e, McGraw-Hill, New york.
7.
go back to reference Railton A, Allen DG (1988) Takayasu’s arteritis in pregnancy. S Afr Med J 73:123PubMed Railton A, Allen DG (1988) Takayasu’s arteritis in pregnancy. S Afr Med J 73:123PubMed
8.
go back to reference Bassa A, Desai DK, Moodley J (1995) Takayasu’s disease and pregnancy. S Afr Med J 85:107–112PubMed Bassa A, Desai DK, Moodley J (1995) Takayasu’s disease and pregnancy. S Afr Med J 85:107–112PubMed
12.
go back to reference Guidozzi F, Louridas G, Grant M, Koller A, King P et al (1991) Takayasu’s arteritis in a pregnant woman. A case report. S Afr J Surg 29:159–160PubMed Guidozzi F, Louridas G, Grant M, Koller A, King P et al (1991) Takayasu’s arteritis in a pregnant woman. A case report. S Afr J Surg 29:159–160PubMed
20.
go back to reference Sharma N, Singh AS (2015) Takayasu arteritis with bilateral renal artery stenosis and left subclavian artery stenosis in pregnancy. J Clin Diagn Res. 9:QD07–QD08. doi: 10.7860/JCDR/2015/14371.6485. Sharma N, Singh AS (2015) Takayasu arteritis with bilateral renal artery stenosis and left subclavian artery stenosis in pregnancy. J Clin Diagn Res. 9:QD07–QD08. doi: 10.7860/JCDR/2015/14371.6485.
24.
Metadata
Title
Pregnancy and Takayasu arteritis: case-based review
Authors
Nirvana Bharuthram
Mohammed Tikly
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 5/2020
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04499-y

Other articles of this Issue 5/2020

Rheumatology International 5/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.